Analysis

{"cpt":"service","style":"2","columns":"3","show":30,"from_category":["farmacogenetics-genotypeization-of-genes-included-in-the-metabolism-of-medications"],"order":"ASC","orderby":"title"}

Clopidogrel sold under the brand name Plavix is a widely used antiplatelet agent to treat and prevent a variety of atherothrombotic diseases.
Research has implicated genetic variations in the CYP2C19 isozyme as at least partly responsible for the variable antiplatelet response seen with clopidogrel.

Warfarin is an anticoagulant commonly used to prevent thrombosis and thromboembolism, the formation of blood clots in blood vessels and their migration elsewhere in the body, respectively.

{"cpt":"service","style":"2","columns":"2","show":30,"from_category":["farmacogenetics-genotypeization-of-genes-included-in-the-metabolism-of-medications"],"order":"ASC","orderby":"title"}

Clopidogrel sold under the brand name Plavix is a widely used antiplatelet agent to treat and prevent a variety of atherothrombotic diseases.
Research has implicated genetic variations in the CYP2C19 isozyme as at least partly responsible for the variable antiplatelet response seen with clopidogrel.

Warfarin is an anticoagulant commonly used to prevent thrombosis and thromboembolism, the formation of blood clots in blood vessels and their migration elsewhere in the body, respectively.

Farmacogenetics – genotypeization of genes Included in the metabolism of medications